Fertility and Sterility
Volume 92, Issue 4 , Pages 1366-1368 , October 2009

Perifollicular blood flow and pregnancy in superovulated intrauterine insemination (IUI) cycles: An observational comparison of recombinant follicle-stimulating hormone (FSH) and urinary gonadotropins

  • Amanda J. O'Leary, MBChB., MRCOG.

      Affiliations

    • Cardiff Assisted Reproduction Unit, University Hospital of Wales, Heath Park, Cardiff, United Kingdom
    • Corresponding Author InformationReprint requests: Amanda J. O'Leary.
    • ,
  • Anthony N. Griffiths, MBBCh., MRCOG.

      Affiliations

    • Cardiff Assisted Reproduction Unit, University Hospital of Wales, Heath Park, Cardiff, United Kingdom
    • ,
  • Janet Evans, MBBCh., FRCOG.

      Affiliations

    • Cardiff Assisted Reproduction Unit, University Hospital of Wales, Heath Park, Cardiff, United Kingdom
    • ,
  • Neil D. Pugh, MBBCh., MRCR.

      Affiliations

    • Department of Medical Physics and Bioengineering, University Hospital of Wales, Heath Park, Cardiff, United Kingdom

Received 22 May 2007 ,Revised 31 January 2009 ,Accepted 18 February 2009.

References 

  1. Rubins JM, Bude RO, Carson PC, Bree RL, Alder RS. Power Doppler ultrasound: a potentially useful alternative to mean frequency-based colour Doppler ultrasound. Radiology. 1994;190:853–856
  2. Sohn C, Weskott HP. The sensitivity of new colour systems in blood flow diagnosis. Surg Endosc. 1997;11:1040–1049
  3. Chui DK, Pugh ND, Walker SM, Gregory L, Shaw RW. Follicular vascularity—the predictive value of transvaginal power Doppler ultrasonography in an in-vitro fertilization programme: a preliminary study. Hum Reprod. 1997;12:191–196
  4. Bhal PS, Pugh ND, Chui DK, Gregory L, Walker SM, Shaw RW. The use of transvaginal power Doppler ultrasonography to evaluate the relationship between perifollicular blood flow and outcome in in-vitro fertilization treatment cycles. Hum Reprod. 1999;14:939–945
  5. Filicori M, Cognigni G, Taraborrelli S, Spettoli D, Ciampaglia W, de Fatis CT. Low- dose human chorionic gonadotrophin therapy can improve sensitivity to exogenous follicle-stimulating hormone in patients with secondary amenorrhea. Fertil Steril. 1999;72:1118–1120
  6. Filicori M, Cognigni GE, Pocognoli P, Tabarelli C, Ferlini F, Perri T, et al. Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle-stimulating hormone. Fertil Steril. 2003;80:390–397
  7. Nyboe Andersen A, Devroey P, Arce J-C. A randomized trial (MERIT) comparing highly purified menotrophin and recombinant FSH in IVF. Hum Reprod. 2005;20(Suppl 1):i19

 A.J.O. has nothing to disclose. A.N.G. has nothing to disclose. J.E. has nothing to disclose. N.D.P. has nothing to disclose.

PII: S0015-0282(09)00465-8

doi: 10.1016/j.fertnstert.2009.02.046

Fertility and Sterility
Volume 92, Issue 4 , Pages 1366-1368 , October 2009

Article Tools